This month, a novel Coronavirus variant from Israel was discovered in a number of countries. A number of cases of the novel strain have been reported in India, the United Kingdom, Thailand, Hong Kong, and Cambodia.
The Israeli variant is a hybrid of two Omicron sub-variants, BA.1 and BA.2. For the time being, the Israeli strain is referred to as the “BA.2.2 variation.”
Last Monday, Israel’s Health Ministry announced the discovery of a new strain of Coronavirus that mixes Omicron BA.1 and BA.2 subvariants.
The novel variant was discovered by taking nose swabs from two passengers during random PCR testing at Ben Gurion Airport.
The patients are in quarantine and are suffering from minor symptoms such as fever, headache, and body pain.
On the other hand, researchers around the world have urged the public to remain calm because the development of a new variety from the mix of two variants is not a novel phenomenon.
Cyprus discovered ‘Deltacron,’ while Israel discovered ‘Flurona,’ in January of this year. The former is a mix of Coronavirus Delta and Omicron strains, whereas the latter is the outcome of a COVID-19 and flu infection.
To read our blog on “WHO addresses the severity of a new variant of highly transmissible Omicron,” click here.
